YES1 and rhabdomyosarcoma: SI221 is a pyrazolo-pyrimidine derivative which exerts inhibitory effects on Yes (a member of SFKs) which is overexpressed in rhabdomyosarcoma, thus reducing proliferation of cancer cells (Bagella and Marchesi, 2016).